Integrated Biopharma (INBP) EBITDA (2010 - 2026)
Integrated Biopharma (INBP) posted EBITDA of -$799,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $660,000 a year earlier.
Powered by 
Analysis
Integrated Biopharma (INBP) EBITDA (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma's EBITDA came in at -$2.41 million.
- In prior fiscal years, Integrated Biopharma's EBITDA was $2.34 million in FY2025 (+319.0%), $558,000 in FY2024 (+18.5%), $471,000 in FY2023 (-84.7%) and $3.08 million in FY2022 (-49.7%).
- Quarterly EBITDA has run from a low of -$1.02 million in fiscal Q3 2026 to a high of $1.08 million in fiscal Q3 2022 over five years.
- The strongest year-over-year quarter for EBITDA in the past five years was fiscal Q3 2024, with growth of 232.3%; the weakest was fiscal Q2 2023, with a decline of 92.6%.
- According to Business Quant data, EBITDA for the three prior fiscal quarters was -$1.02 million (Q3 2026), -$836,000 (Q2 2026) and $240,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 4.76 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 1.17 Bn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | 159.00 Mn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 844.00 Mn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 800.00 Mn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 383.00 Mn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 552.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 128.54 Mn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 170.00 Mn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | -799,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -799,000.00 |
| Mar 31, 2026 | -1.02 Mn |
| Dec 31, 2025 | -836,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 660,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 575,000.00 |
| Jun 30, 2024 | 477,000.00 |
| Mar 31, 2024 | 432,000.00 |
| Dec 31, 2023 | -374,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 130,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 527,000.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 809,000.00 |
| Sep 30, 2021 | 670,000.00 |
API Access
Integrated Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();